According to the Wegovy SmPC, these include nausea (occurring in approximately 44% of patients in clinical trials), vomiting, diarrhoea, constipation, and abdominal discomfort
In our experience working with research teams on peptide storage protocols, the reconstitution step is where most preventable potency loss occurs
I was interested in what they share, what worries them, and how their experiences evolve over time
Aromatase, Adiposity, Aging and Disease: The Hypogonadal-Metabolic-Atherogenic-Disease and Aging Connection. Medical Hypotheses , 56(6), 702-708, 2001